Is alemtuzumab really the single active agent for treatment of chronic lymphocytic leukemia?
- PMID: 19001335
- DOI: 10.1200/JCO.2007.15.7537
Is alemtuzumab really the single active agent for treatment of chronic lymphocytic leukemia?
Comment on
-
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.J Clin Oncol. 2007 Dec 10;25(35):5616-23. doi: 10.1200/JCO.2007.12.9098. Epub 2007 Nov 5. J Clin Oncol. 2007. PMID: 17984186 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources